1. Home
  2. AXSM
  3. AXSM News

Latest Axsome Therapeutics Inc. (AXSM) News on January 22, 2025

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.
AXSM

Investor's Business Daily

9 days ago

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue
AXSM

GlobeNewswire

9 days ago

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Profit Outlook
AXSM

Simply Wall St.

16 days ago

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Profit Outlook

Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
AXSM

Benzinga

22 days ago

Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results

Axsome Flashes A Bearish Signal On Mixed Results In Alzheimer's Agitation
AXSM

Investor's Business Daily

23 days ago

Axsome Flashes A Bearish Signal On Mixed Results In Alzheimer's Agitation

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation
AXSM

GlobeNewswire

23 days ago

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation

Why Is Axsome (AXSM) Down 0.1% Since Last Earnings Report?
AXSM

Zacks

a month ago

Why Is Axsome (AXSM) Down 0.1% Since Last Earnings Report?

Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
AXSM

Benzinga

2 months ago

Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says

Axsome Therapeutics' (NASDAQ:AXSM) growing losses don't faze investors as the stock ascends 5.5% this past week
AXSM

Simply Wall St.

2 months ago

Axsome Therapeutics' (NASDAQ:AXSM) growing losses don't faze investors as the stock ascends 5.5% this past week

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy

Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up
AXSM

Zacks

2 months ago

Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up

AXSM

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Axsome Therapeutics Inc Earnings Call

Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript
AXSM

Motley Fool

2 months ago

Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript

AXSM

GuruFocus.com

2 months ago

Axsome Hits 52-Week High After Surging Nearly 5%--FDA Milestones Could Fuel Even Bigger Gains

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024

Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
AXSM

Zacks

3 months ago

Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
AXSM

GlobeNewswire

3 months ago

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024

3 Bargain Stocks to Buy in a Market That's Priced for Perfection
AXSM

Motley Fool

3 months ago

3 Bargain Stocks to Buy in a Market That's Priced for Perfection

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
AXSM

GlobeNewswire

3 months ago

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12

1 Under-the-Radar Biotech Stock to Buy and Hold
AXSM

Motley Fool

4 months ago

1 Under-the-Radar Biotech Stock to Buy and Hold

Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024
AXSM

GlobeNewswire

4 months ago

Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024

FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
AXSM

Zacks

5 months ago

FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up

Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine
AXSM

GlobeNewswire

5 months ago

Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine

Axsome Therapeutics to Participate in Investor Conferences in September
AXSM

GlobeNewswire

5 months ago

Axsome Therapeutics to Participate in Investor Conferences in September

Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.
AXSM

GlobeNewswire

5 months ago

Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.

Jim Cramer Thinks Axsome Therapeutics Inc (NASDAQ:AXSM) Stock Can Double
AXSM

Insider Monkey

5 months ago

Jim Cramer Thinks Axsome Therapeutics Inc (NASDAQ:AXSM) Stock Can Double

Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript
AXSM

Motley Fool

6 months ago

Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript

Why Axsome Therapeutics Stock Is Sinking Today
AXSM

Motley Fool

6 months ago

Why Axsome Therapeutics Stock Is Sinking Today

Axsome (AXSM) Q2 Loss Widens Y/Y, Revenues Beat Estimates
AXSM

Zacks

6 months ago

Axsome (AXSM) Q2 Loss Widens Y/Y, Revenues Beat Estimates

Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
AXSM

GlobeNewswire

6 months ago

Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Shift From Loss To Profit
AXSM

Simply Wall St.

6 months ago

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Shift From Loss To Profit

Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics
AXSM

Zacks

6 months ago

Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics

Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future
AXSM

Benzinga

6 months ago

Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future

Bull Market and Beyond: 2 Stocks Just Waiting to Soar
AXSM

Motley Fool

6 months ago

Bull Market and Beyond: 2 Stocks Just Waiting to Soar

Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5
AXSM

GlobeNewswire

6 months ago

Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5

Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 7.0% this past week
AXSM

Simply Wall St.

7 months ago

Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 7.0% this past week

Why Axsome Therapeutics Stock Is Sinking Today
AXSM

Motley Fool

7 months ago

Why Axsome Therapeutics Stock Is Sinking Today

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
AXSM

GlobeNewswire

8 months ago

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories

Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month
AXSM

GlobeNewswire

8 months ago

Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month

Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
AXSM

GlobeNewswire

8 months ago

Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month

Axsome Therapeutics to Participate in Upcoming Investor Conferences
AXSM

GlobeNewswire

8 months ago

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
AXSM

GlobeNewswire

8 months ago

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting
AXSM

GlobeNewswire

8 months ago

Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting

3 Monster Stocks in the Making You Can Buy Right Now
AXSM

Motley Fool

8 months ago

3 Monster Stocks in the Making You Can Buy Right Now

15 Most Depressed States in the US
AXSM

Insider Monkey

8 months ago

15 Most Depressed States in the US

Prediction: These 2 Growth Stocks Could Triple By 2030
AXSM

Motley Fool

8 months ago

Prediction: These 2 Growth Stocks Could Triple By 2030

Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
AXSM

Simply Wall St.

8 months ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Axsome Therapeutics to Present at Upcoming Investor Conferences
AXSM

GlobeNewswire

8 months ago

Axsome Therapeutics to Present at Upcoming Investor Conferences

Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
AXSM

Zacks

8 months ago

Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
AXSM

Insider Monkey

8 months ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript

AXSM

GuruFocus.com

9 months ago

Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...

AXSM

Thomson Reuters StreetEvents

9 months ago

Q1 2024 Axsome Therapeutics Inc Earnings Call

Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
AXSM

Motley Fool

9 months ago

Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
AXSM

GlobeNewswire

9 months ago

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?
AXSM

Zacks

9 months ago

Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?

Axsome Therapeutics Recognizes May as Mental Health Awareness Month
AXSM

GlobeNewswire

9 months ago

Axsome Therapeutics Recognizes May as Mental Health Awareness Month

15 Most Black States in the US
AXSM

Insider Monkey

9 months ago

15 Most Black States in the US

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
AXSM

GlobeNewswire

9 months ago

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
AXSM

GlobeNewswire

9 months ago

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6

Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study
AXSM

Zacks

10 months ago

Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study

Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)
AXSM

GuruFocus.com

10 months ago

Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
AXSM

GlobeNewswire

10 months ago

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder

30 Countries with the Lowest Depression Rates
AXSM

Insider Monkey

10 months ago

30 Countries with the Lowest Depression Rates

20 Cloudiest Cities in the U.S., Ranked
AXSM

Insider Monkey

10 months ago

20 Cloudiest Cities in the U.S., Ranked

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
AXSM

GlobeNewswire

10 months ago

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
AXSM

GlobeNewswire

10 months ago

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
AXSM

Motley Fool

10 months ago

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Axsome Triumphs Over Major Depressive Disorder With Auvelity
AXSM

GuruFocus.com

10 months ago

Axsome Triumphs Over Major Depressive Disorder With Auvelity

Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
AXSM

Zacks

10 months ago

Axsome (AXSM) Begins Dosing in Depression Study on Sunosi

Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
AXSM

GlobeNewswire

10 months ago

Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder

11 Oversold NASDAQ Stocks To Buy Right Now
AXSM

Insider Monkey

10 months ago

11 Oversold NASDAQ Stocks To Buy Right Now

Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
AXSM

GlobeNewswire

a year ago

Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
AXSM

GlobeNewswire

a year ago

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
AXSM

InvestorPlace

a year ago

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024

3 Biotech Stocks to Buy and Hold for the Next 10 Years
AXSM

Motley Fool

a year ago

3 Biotech Stocks to Buy and Hold for the Next 10 Years

Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat
AXSM

Zacks

a year ago

Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript
AXSM

Insider Monkey

a year ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript

AXSM

Thomson Reuters StreetEvents

a year ago

Q4 2023 Axsome Therapeutics Inc Earnings Call

Axsome Therapeutics Inc (AXSM) Reports Robust Revenue Growth in Q4 and Full Year 2023
AXSM

GuruFocus.com

a year ago

Axsome Therapeutics Inc (AXSM) Reports Robust Revenue Growth in Q4 and Full Year 2023

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AXSM

GlobeNewswire

a year ago

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AXSM

Zacks

a year ago

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Breakeven On The Horizon For Axsome Therapeutics, Inc. (NASDAQ:AXSM)
AXSM

Simply Wall St.

a year ago

Breakeven On The Horizon For Axsome Therapeutics, Inc. (NASDAQ:AXSM)

2 Stocks That Could Double Your Money in 5 Years
AXSM

Motley Fool

a year ago

2 Stocks That Could Double Your Money in 5 Years

Wayfair (NYSE:W) dips 10% this week as increasing losses might not be inspiring confidence among its investors
AXSM

Simply Wall St.

a year ago

Wayfair (NYSE:W) dips 10% this week as increasing losses might not be inspiring confidence among its investors

AutoNation Announces Fourth Quarter 2023 Earnings Conference Call and Audio Webcast Scheduled for Tuesday, February 13, 2024
AXSM

PR Newswire

a year ago

AutoNation Announces Fourth Quarter 2023 Earnings Conference Call and Audio Webcast Scheduled for Tuesday, February 13, 2024

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story
AXSM

Motley Fool

a year ago

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

AXSM

GlobeNewswire

a year ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis
AXSM

GlobeNewswire

a year ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

AXSM

Business Wire

a year ago

Form 8.3 - DX (Group) plc

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research
AXSM

GlobeNewswire

a year ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
AXSM

CNW Group

a year ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030
AXSM

GlobeNewswire

a year ago

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030
AXSM

GlobeNewswire

a year ago

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
AXSM

Barrons.com

a year ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education
AXSM

PR Newswire

a year ago

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education

CNA Financial (CNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
AXSM

Zacks

a year ago

CNA Financial (CNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Big Tech earnings: What markets are expecting this week
AXSM

Yahoo Finance Video

a year ago

Big Tech earnings: What markets are expecting this week

Murphy Oil Corporation (NYSE:MUR) Q4 2023 Earnings Call Transcript
AXSM

Insider Monkey

a year ago

Murphy Oil Corporation (NYSE:MUR) Q4 2023 Earnings Call Transcript

Baillie Gifford Trims Stake in Samsara Inc
AXSM

GuruFocus.com

a year ago

Baillie Gifford Trims Stake in Samsara Inc

Share on Social Networks: